Design and comparison of wedge shaped midline block with rectangular block used in early stage cervical cancers.
OBJECTIVE
Design of an universal wedge shaped midline block for early stage cervical cancers to get uniform dose distribution around the target volume.


METHODS
The method of fabrication of wedge shaped midline block is discussed for treatment of early stage cervical cancers based on the configuration of 137Cs pellets used in intracavitary applications and along with external photon beams obtained by using 60Co teletherapy machine and 6 and 10 MV linear accelerators.


RESULTS
The dosimetric measurements are carried out to confirm the adequacy of thickness and shape of the block using radiation field analyzer for all the 3 energies.


CONCLUSIONS
The dose distribution comparison has been made with wedge shaped midline block and conventional rectangular shields to show its superiority in getting homogeneous dose distribution around target volume. The shift in 184 intracavitary applications is analyzed in actual clinical applications with respect to central axis of external beams and its comparison is made with both types of blocks. With the shift of 1 cm towards lateral from midline an overdose can occur upto 12 Gy at certain points with rectangular block compared to wedge shaped midline block.


CONCLUSIONS
Since the preparation of individual wedge shaped midline block for every application will be a difficult process for busy centers, the single wedge shaped midline block for each energy is more convenient to handle for busy centers instead of individualized compensating blocks for every intracavitary application.
Avadhani
J S
JS
Department of Medical Physics, Tata Memorial Hospital, Mumbai, India.
Deshpande
D D
DD
Pradhan
A S
AS
Viswanathan
P S
PS
Shrivastava
S K
SK
Dinshaw
K A
KA
D001918:Brachytherapy / Q000295:instrumentation* / Q000706:statistics & numerical data; D002588:Cesium Radioisotopes / Q000627:therapeutic use*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D004867:Equipment Design; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D019047:Phantoms, Imaging; D011835:Radiation Protection / Q000295:instrumentation* / Q000706:statistics & numerical data; D011867:Radioisotope Teletherapy / Q000295:instrumentation* / Q000706:statistics & numerical data; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000532:radiotherapy*
D002588:Cesium Radioisotopes; D003037:Cobalt Radioisotopes